An inhalable pharmaceutical composition suitable for giving improved feedback to the patient about the inhalation of the metered doses in a range between 5 miligram and 10 miligram and suitable for use in a dry powder inhaler comprises 70 mass% 99 5 mass% of pharmaceutically acceptable carrier suitable for use in dry powder inhalation formulation and 0 5 mass% 30 mass% of one or two pharmaceutically active ingredient(s).